Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

56 та иш

Иш: Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome

  1. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

    Tingjuan Ni, Na Lin, Wenqiang Lu +4

    Мақола20203 иқтибос
    ABI

  2. Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism

    Joshua Silva, Xin Yu, Renita Moradian +6

    Мақола20203 иқтибос
    ABI

  3. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

    Jianjin Shi, Yue Zhao, Kun Wang +7

    Мақола20153 иқтибос
    ABI

  4. Mechanisms of hepatic stellate cell activation

    Takuma Tsuchida, Scott L. Friedman

    Шарҳ мақола20173 иқтибос
    ABI

  5. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease

    G. Paumgartner, Ulrich Beuers

    Шарҳ мақола20042 иқтибос
    ABI

  6. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability

    Dan Liu, Yiqin Mao, Lijun Ding +1

    Шарҳ мақола20192 иқтибос
    ABI

  7. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1

    Zhenzhu Sun, Wenqiang Lu, Na Lin +6

    Мақола20202 иқтибос
    ABI

  8. Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice

    Dafeng Yang, Zhousheng Yang, Lei Chen +15

    Мақола20202 иқтибос
    ABI

  9. Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis

    Quancheng Cheng, Jing Fan, Xin-Wei Deng +6

    Мақола20202 иқтибос
    ABI

  10. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism

    Sijing Dong, Min Zhu, Ke Wang +5

    Мақола20212 иқтибос
    ABI

  11. Dihydromyricetin alleviates Escherichia coli lipopolysaccharide-induced hepatic injury in chickens by inhibiting the NLRP3 inflammasome

    Chenxi Shi, Jiaqi Wang, Ruichen Zhang +7

    Мақола20222 иқтибос
    ABI

  12. Dihydromyricetin prevents obesity <i>via</i> regulating bile acid metabolism associated with the farnesoid X receptor in <i>ob</i>/<i>ob</i> mice

    Yanjun Song, Le Sun, Pei Ma +2

    Мақола20222 иқтибос
    ABI

  13. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

    Xiaoqi Li, Xin Wang, Binyu Wang +7

    Мақола20222 иқтибос
    ABI

  14. Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease

    Hang Gong, Huimei Xu, Muyang Li +1

    Шарҳ мақола20222 иқтибос
    ABI

  15. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis

    Zheming Xu, Minjing Zhang, Wenwen Wang +19

    Мақола20232 иқтибос
    ABI

  16. Preparation, characterization and protective effect of chitosan - Tripolyphosphate encapsulated dihydromyricetin nanoparticles on acute kidney injury caused by cisplatin

    Qiaohua Yan, Meiqing Li, Liying Dong +12

    Мақола20232 иқтибос
    ABI

  17. Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury

    Doaa Emad, Asmaa M. A. Bayoumi, Sahar M. Gebril +2

    Мақола20242 иқтибос
    ABI

  18. A role for mitochondria in NLRP3 inflammasome activation

    Rongbin Zhou, Amir S. Yazdi, Philippe Menu +1

    Мақола20102 иқтибос
    ABI

  19. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition

    Rebecca C. Coll, James R. Hill, Christopher J. Day +8

    Мақола20192 иқтибос
    ABI

  20. Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages

    Cornelius Y. Taabazuing, Marian C. Okondo, Daniel A. Bachovchin

    Мақола20172 иқтибос
    ABI

  21. Estrogen accelerates the resolution of inflammation in macrophagic cells

    Alessandro Villa, Nicoletta Rizzi, Elisabetta Vegeto +2

    Мақола20152 иқтибос
    ABI

  22. Sex differences in immune responses

    Sabra L. Klein, Katie L. Flanagan

    Шарҳ мақола20162 иқтибос
    ABI

  23. Dihydromyricetin regulates the miR-155-5p/SIRT1/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury

    Qing Ma, Shuo Huang, Mei-ya Li +13

    Мақола20252 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI